摘要
目的评价我院2008-2010年抗肿瘤药的应用情况和发展趋势。方法采用金额排序法、用药频度(DDDs)分析法,对我院2008-2010年抗肿瘤药的应用情况进行统计与分析。结果3年中,抗肿瘤药销售金额、DDDs均逐年增加,香菇多糖DDDs排名稳居榜首,多西他赛销售金额位于前2位。结论我院抗肿瘤药品种基本保持稳定,并具有价格更合理、疗效更确切、不良反应更小的趋势。
Objective To evaluate the application and trends of antineoplastics in our hospital from 2008 to 2010.Methods The antineoplastics use in our hospital from 2008 to 2010 were statistically analyzed by the analysis of consumption sum and DDDs.Results In the 3 years,both consumption sum and DDDs of antineoplastics increased year by year.The DDDs of lentinan ranked for the first place,and docetaxel for injection was in the top 2 of sales amount.Conclusion The antineoplastics use in our hospital basically remain stable in category in recent years,that focus on the reasonable price,exact therapeutic effect and less adverse reaction.
出处
《实用药物与临床》
CAS
2012年第1期36-38,共3页
Practical Pharmacy and Clinical Remedies
关键词
抗肿瘤药
销售金额
用药频度
Antineoplastic drugs
Consumption sum
DDDs
